BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Inoue, Y
Right arrow Articles by Omata, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Inoue, Y
Right arrow Articles by Omata, M

False positive uptake of metaiodobenzylguanidine in hepatocellular carcinoma

Y Inoue, MD1, M Akahane, MD1, T Kitazawa, MD2, H Ijichi, MD2, S Obi, MD2, K Yoshikawa, MD1, K Ohtomo, MD3 and M Omata, MD2

1 Department of Radiology, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639 and Departments of 2 Gastroenterology and 3 Radiology, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan



View larger version (174K):

[in a new window]
 
Figure 1. Anterior abdominal image obtained 4 h postinjection of 123I-metaiodobenzylguanidine. Photopenic areas are seen in the liver.

 


View larger version (175K):

[in a new window]
 
Figure 2. Anterior abdominal view obtained 24 h post injection of 123I-metaiodobenzylguanidine. Inhomogeneously increased uptake is noted in the liver.

 


View larger version (107K):

[in a new window]
 
Figure 3. CT of the upper abdomen imaged during the portal venous phase after contrast medium injection. A large mass lesion is demonstrated in the liver.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 2002 by the British Institute of Radiology.